Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2022
/
Article
/
Tab 2
/
Research Article
Investigating the Mechanism of Rhizoma Coptidis-Eupatorium fortunei Medicine in the Treatment of Type 2 Diabetes Based on Network Pharmacology and Molecular Docking
Table 2
Molecular docking results of core targets and key active ingredients.
Hub targets
Quercetin (kcal/mol)
Luteolin (kcal/mol)
Berberine (kcal/mol)
Palmatine (kcal/mol)
Coptisine (kcal/mol)
ESR1
-4.99
-4.82
-7.72
-8.05
-8.33
MAPK1
-5.35
-5.20
-8.14
-8.04
-8.25
AKT1
-6.37
-6.54
-8.72
-8.28
-8.95
TP53
-4.04
-4.52
-6.35
-6.26
-6.59
IL6
-6.48
-6.37
-8.39
-8.07
-8.53
JUN
-4.45
-4.90
-9.22
-8.78
-9.58